AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 11.59 |
Market Cap | 1.17B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.5 |
PE Ratio (ttm) | -5.45 |
Forward PE | n/a |
Analyst | Hold |
Ask | 14.42 |
Volume | 432,699 |
Avg. Volume (20D) | 746,086 |
Open | 13.42 |
Previous Close | 13.31 |
Day's Range | 13.29 - 13.70 |
52-Week Range | 6.62 - 16.41 |
Beta | undefined |
About MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. T...
Analyst Forecast
According to 6 analyst ratings, the average rating for MD stock is "Hold." The 12-month stock price forecast is $15.75, which is an increase of 15.55% from the latest price.
Next Earnings Release
Analysts project revenue of $486.22M, reflecting a -2.06% YoY shrinking and earnings per share of 0.36, making a 12.50% increase YoY.
2 months ago · seekingalpha.com
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call TranscriptPediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chi...